Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Enteral Collagen Peptide Protein Market by Form, Age Group and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030.
Collagen peptide protein is a protein derived from animal collagen. Collagen peptides are a versatile source of protein and an important element of healthy nutrition. Their nutritional and physiological properties promote the health of bones & joints and prevent osteoarthritis.
Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients, who are unable to consume sufficient nutrients orally but whose gastrointestinal function help in digestion and absorption.
Enteral collagen peptide protein products are used when a patient is unable to eat due to some illness, has swallowing difficulties, or has undergone surgery that may interfere with the normal eating process. In this process, collagen peptides protein are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.
Enteral collagen peptide protein supplements are prescribed to patients suffering from chronic diseases such as malnutrition, osteoarthritis, and osteoporosis. Generally, collagen peptides protein enteral feeding is used in hospitals & clinics, home care, and nursing home.
The growth of the global enteral collagen peptide protein market is majorly driven by rise in prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in application of enteral collagen peptide proteins in the healthcare sector.
Furthermore, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide lucrative opportunities for the growth of the global market.
Increase in prevalence of chronic disorders
Surge in geriatric population
Rise in number of malnutrition cases
Poor demand in underdeveloped countries
High growth potential in emerging markets
COVID-19 impact analysis on enteral collagen peptide protein market
Danone S.A (Nutricia)
Dermarites Industries LLC
Medline Industries, Inc
Global Health Products, Inc.
OP2 labs, LLC
Fresenius Kabi AG
Weishardt Holding SA
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of four regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
Adults (Above 18)
Pediatrics (Below 18)
By End User
Hospitals & clinics
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
For more information about this report visit https://www.researchandmarkets.com/r/jy0h29
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900